GR
Guardian Pharmacy Services, Inc.
GRDN · NYSE
$48.04 +3.33% (+$1.55)
1M +22.34%
Market Cap $2.94B
P/E Ratio 44.65x
Div. Yield -
ROE 30.80%
Bulios Fair Price
$29
39.6% downside
Current Price
$48.04
Undervalued Fair Value Overvalued
According to Bulios Fair Price, GRDN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
18 /100
Expensive P/B 11.98x
P/S 2.01x
P/E 44.65x
Growth
87 /100
Growing Book val. growth 68.87%
FCF growth 36.47%
EPS growth 10.38%
Profitability
33 /100
Weak FCF margin 5.45%
Op. margin 6.27%
Gross margin 21.63%
Quality
100 /100
Excellent Asset turnover 3.30x
ROA 14.86%
ROIC 21.45%
Debt
97 /100
Low Net debt/EBITDA -0.48x
Int. coverage 152.85x
Debt/Equity 0.14x
Stability
33 /100
Unstable Profitable years 1
EPS volatility 362.83%
Beta 0.10x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRDN
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Fred Burke
Employees
3,600
Headquarters
Atlanta
Upcoming events
09 NOV
Earnings
Upcoming earnings report